Cefarka S 1000mg/500mg Injection
Marketer
Mediarka Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Cefarka S 1000mg/500mg Injection
Combiflox, a dual-action injectable medication (1000mg/500mg), combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under medical guidance; complete the prescribed regimen, even with symptom improvement, to ensure efficacy. Premature cessation may compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; intensified symptoms necessitate immediate medical attention. Seek immediate medical help for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all current medications, including those for pre-existing conditions, to your physician before initiating treatment. Consult your doctor prior to use if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if experiencing somnolence or vertigo. Adequate rest, proper nutrition, and hydration are vital for optimal recovery. Follow-up laboratory and diagnostic tests may be conducted to monitor therapeutic response.
Uses of Cefarka S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Cefarka S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
Common Side effects of Cefarka S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefarka S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cefarka S 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefarka S 1000mg/500mg Injection, offer a dual-action approach to bacterial infections. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Cefarka S 1000mg/500mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefarka S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals have indicated minimal or absent harm to the fetus; nonetheless, clinical data from human studies remain scarce.
Breast feedingCAUTION
Administering Cefarka S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Cefarka S 1000mg/500mg Injection can potentially reduce awareness, impair visual acuity, and induce drowsiness or dizziness. Operation of a motor vehicle should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Cefarka S 1000mg/500mg Injection use in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
The injectable medication, Cefarka S 1000mg/500mg, requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Cefarka S 1000mg/500mg injection is unnecessary for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Cefarka S 1000mg/500mg Injection :
Should you omit a scheduled dose of Cefarka S 1000mg/500mg Injection, seek medical advice.
Facts to Know About Cefarka S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently